Microsoft Corporation vs. Starling Oncology, Inc. Common Stock
Microsoft Corporation (MSFT) comes out ahead, leading on 1 of 1 compared factors.
Size & Scale
| MSFT | STLN | |
|---|---|---|
| Market Cap | $3.76 trillion | $627.80 million |
| Revenue (TTM) | $331.84 billion | — |
| Net Income (TTM) | $133.75 billion | — |
MSFT leads on 1 of 1 size & scale factors.
Valuation
| MSFT | STLN | |
|---|---|---|
| P/E Ratio | 28.19 | — |
| Price / Book | 8.49 | — |
| Price / Sales | 11.32 | — |
MSFT and STLN split the valuation factors evenly.
Profitability
| MSFT | STLN | |
|---|---|---|
| Net Margin | 40.31% | — |
| Return on Equity | 30.23% | — |
MSFT and STLN split the profitability factors evenly.
Dividend
| MSFT | STLN | |
|---|---|---|
| Dividend Yield | 0.72% | — |
| Payout Ratio | 20.28 | — |
MSFT and STLN split the dividend factors evenly.
Risk & Sentiment
| MSFT | STLN | |
|---|---|---|
| Short Interest | 0.54% | — |
MSFT and STLN split the risk & sentiment factors evenly.
Dig deeper: MSFT overview, MSFT financials, STLN overview, STLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.